LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Determination of pentoxifylline efficacy on microalbuminuria in patients with type-2 diabetes.

    Shayanpour, Shokouh / Mehri, Aslan / Hayati, Fatemeh / Zakerkish, Mehrnoosh / Beladi Mousavi, Seyed Seifollah / Hoseinynejad, Khojasteh

    Recenti progressi in medicina

    2024  Volume 115, Issue 1, Page(s) 15–20

    Abstract: Background: Diabetic nephropathy is a clinical syndrome characterized by persistent albuminuria and progressive impairment in renal function. Pentoxifylline is a non-specific inhibitor of phosphodiesterase with anti-inflammatory properties which may ... ...

    Abstract Background: Diabetic nephropathy is a clinical syndrome characterized by persistent albuminuria and progressive impairment in renal function. Pentoxifylline is a non-specific inhibitor of phosphodiesterase with anti-inflammatory properties which may have therapeutic potency in patients with diabetic kidney disease.
    Objective: The present study is aimed at evaluating the efficacy of pentoxifylline as a treatment strategy for alleviating the microalbuminuria in type-2 diabetic patients with nephropathy.
    Methods: This double-blind randomized clinical trial was performed on outpatients with type 2 diabetic nephropathy who presented urine albumin excretion of 30-300 mg per 24 hours on at least three consecutive occasions. A total of 58 patients were randomly assigned to the treatment and control groups. The treatment group (n=29) received pentoxifylline (400 mg/day) for 3 months in addition to the standard drugs for diabetic nephropathy (Raas blockers), while the control group (n=29) received placebo as add-on therapy. Finally, urine albumin test was measured before and after 3 months of treatment and compared between the two groups.
    Results: Before the intervention, no significant difference in the levels of albuminuria was observed between the two groups (153.21±130.80 mg/day vs. 159.93 ±130.45; p=0.845); but after 12 weeks of treatment, albuminuria in the treatment group was significantly reduced compared to the placebo group (29.59 ±27.88 mg/day vs. 160.48±129.53 mg/day; p<0.0001). At the end of the study, the response rate to treatment (more than 50% reduction in albuminuria) was 89.7% in the pentoxifylline group, while no response to treatment was observed in the placebo group (p<0.0001).
    Conclusions: Pentoxifylline as add-on therapy to the conventional treatment (Raas blockers) may reduce the microalbuminuria in patients with diabetic nephropathy without any side effects.
    MeSH term(s) Humans ; Albuminuria/drug therapy ; Albuminuria/etiology ; Albuminuria/urine ; Pentoxifylline/therapeutic use ; Diabetic Nephropathies/drug therapy ; Diabetic Nephropathies/urine ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Albumins/therapeutic use ; Double-Blind Method
    Chemical Substances Pentoxifylline (SD6QCT3TSU) ; Albumins
    Language English
    Publishing date 2024-01-03
    Publishing country Italy
    Document type Randomized Controlled Trial ; Journal Article
    ZDB-ID 138266-4
    ISSN 2038-1840 ; 0034-1193
    ISSN (online) 2038-1840
    ISSN 0034-1193
    DOI 10.1701/4169.41640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Hepatitis E Virus Infection Among Chronic Hemodialysis.

    Shayanpour, Shokouh / Hayati, Fatemeh

    Jundishapur journal of microbiology

    2016  Volume 9, Issue 3, Page(s) e26645

    Language English
    Publishing date 2016-03-17
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2815501-4
    ISSN 2008-4161 ; 2008-3645
    ISSN (online) 2008-4161
    ISSN 2008-3645
    DOI 10.5812/jjm.26645
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The Effect of Synbiotic and Probiotic Supplementation on Mental Health Parameters in Patients Undergoing Hemodialysis: A Double-blind, Randomized, Placebo-controlled Trial.

    Haghighat, Neda / Mohammadshahi, Majid / Shayanpour, Shokouh / Haghighizadeh, Mohammad Hossein / Rahmdel, Samaneh / Rajaei, Majdadin

    Indian journal of nephrology

    2021  Volume 31, Issue 2, Page(s) 149–156

    Abstract: Introduction: The purpose of this double-blind clinical trial, was to examine the effect of supplementation with the synbiotic and probiotic on the mental health, quality of life, and anemia in HD patients.: Methods: Seventy-five HD patients were ... ...

    Abstract Introduction: The purpose of this double-blind clinical trial, was to examine the effect of supplementation with the synbiotic and probiotic on the mental health, quality of life, and anemia in HD patients.
    Methods: Seventy-five HD patients were randomly assigned to receive the synbiotic (
    Results: From baseline to 12 weeks, synbiotic and probiotic supplementation resulted in a significant decrease in BDI and BAI score in comparison to the placebo (
    Conclusion: Overall, 12 weeks of synbiotic and probiotic supplementation resulted in an improvement in mental health and anemia compared with the placebo, whereas they failed to enhance the quality of life in HD patients.
    Language English
    Publishing date 2021-01-27
    Publishing country India
    Document type Journal Article
    ZDB-ID 2134388-3
    ISSN 1998-3662 ; 0971-4065
    ISSN (online) 1998-3662
    ISSN 0971-4065
    DOI 10.4103/ijn.IJN_341_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Effects of Synbiotics and Probiotics Supplementation on Serum Levels of Endotoxin, Heat Shock Protein 70 Antibodies and Inflammatory Markers in Hemodialysis Patients: a Randomized Double-Blinded Controlled Trial

    Haghighat, Neda / Mohammadshahi, Majid / Shayanpour, Shokouh / Haghighizadeh, Mohammad Hossein

    Probiotics and antimicrobial proteins. 2020 Mar., v. 12, no. 1

    2020  

    Abstract: The aim of this study was to investigate the effects of probiotic and synbiotic supplementation on serum inflammatory markers, endotoxin, and anti-HSP70 in hemodialysis (HD) patients. This study was a randomized, double-blind, placebo-controlled trial. ... ...

    Abstract The aim of this study was to investigate the effects of probiotic and synbiotic supplementation on serum inflammatory markers, endotoxin, and anti-HSP70 in hemodialysis (HD) patients. This study was a randomized, double-blind, placebo-controlled trial. Seventy-five hemodialysis patients who met the inclusion and exclusion criteria were randomly assigned for 12 weeks to one of the three arms: synbiotics [n = 23; 15 g of prebiotics, 5 g of probiotic powder containing Lactobacillus acidophilus T16, Bifidobacterium bifidum BIA-6, Bifidobacterium lactis BIA-6, and Bifidobacterium longum LAF-5 (2.7 × 107 CFU/g each)], probiotics [n = 23; 5 g probiotics as in synbiotic group with 15 g of maltodextrin in the sachet as placebo], and placebo [n = 19; 20 g of maltodextrin in the sachet]. Blood and feces were collected at baseline and after intervention. Serum high sensitive C-reactive protein (hs-CRP), interleukin-6, endotoxin, and anti-heat shock protein 70 antibodies (anti-HSP70) were measured. The number of fecal colonies was determined using the plate-counting method. The mean serum level of hs-CRP, anti-HSP70, and endotoxin decreased significantly between groups (p = 0.007, p = 0.037, and p = 0.036, respectively). For the synbiotic group, the mean changes in hs-CRP and IL-6 were significantly lower than for the placebo (p < 0.001 and p < 0.001, respectively) and probiotic group (p = 0.011 and p = 0.008, respectively). Anti-HSP70 mean changes in the synbiotic and probiotic groups differed from the placebo group (p = 0.002 and p = 0.013, respectively). Administration of synbiotics was more effective than probiotics for improvement of inflammatory markers, endotoxin and anti-HSP70 serum levels. Trial registration number: IRCT2017041233393N1
    Keywords Bifidobacterium animalis subsp. lactis ; Bifidobacterium bifidum ; Bifidobacterium longum ; C-reactive protein ; Lactobacillus acidophilus ; antibodies ; blood serum ; endotoxins ; feces ; heat-shock protein 70 ; hemodialysis ; interleukin-6 ; maltodextrins ; patients ; plate count ; prebiotics ; probiotics ; randomized clinical trials
    Language English
    Dates of publication 2020-03
    Size p. 144-151.
    Publishing place Springer US
    Document type Article
    ZDB-ID 2487792-X
    ISSN 1867-1314 ; 1867-1306
    ISSN (online) 1867-1314
    ISSN 1867-1306
    DOI 10.1007/s12602-018-9509-5
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article: Arteriovenous Fistula Recirculation in Hemodialysis.

    Shayanpour, Shokouh / Faramarzi, Mohammad

    Nephro-urology monthly

    2015  Volume 7, Issue 4, Page(s) e27474

    Language English
    Publishing date 2015-07-22
    Publishing country Iran
    Document type Journal Article
    ISSN 2251-7006
    ISSN 2251-7006
    DOI 10.5812/numonthly.27474
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Effects of Synbiotics and Probiotics Supplementation on Serum Levels of Endotoxin, Heat Shock Protein 70 Antibodies and Inflammatory Markers in Hemodialysis Patients: a Randomized Double-Blinded Controlled Trial.

    Haghighat, Neda / Mohammadshahi, Majid / Shayanpour, Shokouh / Haghighizadeh, Mohammad Hossein

    Probiotics and antimicrobial proteins

    2019  Volume 12, Issue 1, Page(s) 144–151

    Abstract: The aim of this study was to investigate the effects of probiotic and synbiotic supplementation on serum inflammatory markers, endotoxin, and anti-HSP70 in hemodialysis (HD) patients. This study was a randomized, double-blind, placebo-controlled trial. ... ...

    Abstract The aim of this study was to investigate the effects of probiotic and synbiotic supplementation on serum inflammatory markers, endotoxin, and anti-HSP70 in hemodialysis (HD) patients. This study was a randomized, double-blind, placebo-controlled trial. Seventy-five hemodialysis patients who met the inclusion and exclusion criteria were randomly assigned for 12 weeks to one of the three arms: synbiotics [n = 23; 15 g of prebiotics, 5 g of probiotic powder containing Lactobacillus acidophilus T16, Bifidobacterium bifidum BIA-6, Bifidobacterium lactis BIA-6, and Bifidobacterium longum LAF-5 (2.7 × 10
    MeSH term(s) Adult ; Aged ; Antibodies/blood ; Biomarkers/blood ; C-Reactive Protein/metabolism ; Double-Blind Method ; Endotoxins/blood ; Female ; HSP70 Heat-Shock Proteins/immunology ; Humans ; Interleukin-6/blood ; Male ; Middle Aged ; Probiotics/administration & dosage ; Renal Dialysis ; Synbiotics/administration & dosage
    Chemical Substances Antibodies ; Biomarkers ; Endotoxins ; HSP70 Heat-Shock Proteins ; IL6 protein, human ; Interleukin-6 ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2019-01-08
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 2487792-X
    ISSN 1867-1314 ; 1867-1306
    ISSN (online) 1867-1314
    ISSN 1867-1306
    DOI 10.1007/s12602-018-9509-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study

    Haghighat, Neda / Mohammadshahi, Majid / Shayanpour, Shokouh / Haghighizadeh, Mohammad Hossein

    Probiotics and antimicrobial proteins. 2019 Dec., v. 11, no. 4

    2019  

    Abstract: The aim of this study was to investigate the effect of synbiotic and probiotic supplementation on serum vascular dysfunction and necrosis markers in hemodialysis (HD) patients. In this randomized, double-blind, placebo-controlled trial, 75 HD patients ... ...

    Abstract The aim of this study was to investigate the effect of synbiotic and probiotic supplementation on serum vascular dysfunction and necrosis markers in hemodialysis (HD) patients. In this randomized, double-blind, placebo-controlled trial, 75 HD patients were randomly assigned to either the synbiotic or probiotic or placebo group. The patients in the synbiotic group received 15 g of prebiotics and 5 g probiotic powder containing Lactobacillus acidophilus strain T16 (IBRC-M10785), Bifidobacterium bifidum strain BIA-6, Bifidobacterium lactis strain BIA-6, Bifidobacterium longum strain LAF-5 (2.7 × 10⁷ CFU/g each) in sachets (n = 25), whereas the probiotic group received 5 g probiotics same to the first group with 15 g of maltodextrin powder in sachets (n = 25) and the placebo group received 20 g of maltodextrin powder in sachets (n = 25) for 12 weeks. At baseline and the end of the study, serum concentrations of soluble intercellular adhesion molecule type 1 (sICAM-1), soluble vascular cell adhesion molecule type 1 (sVCAM-1), cytokeratin 18 (CK-18) as the necrosis marker, uric acid, and phosphate levels were measured. Feces also were collected for microbiota colony counting. Serum ICAM-1 level reduced significantly in the synbiotic group after the intervention period (P = 0.02), and this reduction was significantly different in the synbiotic group in comparison to the placebo group (P = 0.03). Serum levels of VCAM-1 and CK-18 were not significantly different between the groups. However, the reduction in serum levels of VCAM-1 in the synbiotic group was significantly higher in comparison to the placebo group (P = 0.01). Multivariate linear regression analysis revealed that ∆ phosphate was the sole independent determinant of ∆ICAM-1 (P = 0 < 001). The study indicated that synbiotic supplementation reduced serum ICAM-1 level, which is a risk factor for cardiovascular diseases in HD patients, but has no effect on the necrosis marker. Trial registration: www.irct.ir (IRCT2017041233393N1).
    Keywords Bifidobacterium animalis subsp. lactis ; Bifidobacterium bifidum ; Bifidobacterium longum ; Lactobacillus acidophilus ; blood serum ; cardiovascular diseases ; endothelial cells ; feces ; hemodialysis ; intercellular adhesion molecule-1 ; maltodextrins ; necrosis ; patients ; phosphates ; placebos ; prebiotics ; probiotics ; randomized clinical trials ; regression analysis ; risk factors ; uric acid ; vascular cell adhesion molecules
    Language English
    Dates of publication 2019-12
    Size p. 1210-1218.
    Publishing place Springer US
    Document type Article
    ZDB-ID 2487792-X
    ISSN 1867-1314 ; 1867-1306
    ISSN (online) 1867-1314
    ISSN 1867-1306
    DOI 10.1007/s12602-018-9477-9
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

    Haghighat, Neda / Mohammadshahi, Majid / Shayanpour, Shokouh / Haghighizadeh, Mohammad Hossein

    Probiotics and antimicrobial proteins

    2018  Volume 11, Issue 4, Page(s) 1210–1218

    Abstract: The aim of this study was to investigate the effect of synbiotic and probiotic supplementation on serum vascular dysfunction and necrosis markers in hemodialysis (HD) patients. In this randomized, double-blind, placebo-controlled trial, 75 HD patients ... ...

    Abstract The aim of this study was to investigate the effect of synbiotic and probiotic supplementation on serum vascular dysfunction and necrosis markers in hemodialysis (HD) patients. In this randomized, double-blind, placebo-controlled trial, 75 HD patients were randomly assigned to either the synbiotic or probiotic or placebo group. The patients in the synbiotic group received 15 g of prebiotics and 5 g probiotic powder containing Lactobacillus acidophilus strain T16 (IBRC-M10785), Bifidobacterium bifidum strain BIA-6, Bifidobacterium lactis strain BIA-6, Bifidobacterium longum strain LAF-5 (2.7 × 10
    MeSH term(s) Adult ; Aged ; Bifidobacterium bifidum/physiology ; Cell Adhesion Molecules/genetics ; Cell Adhesion Molecules/metabolism ; Dietary Supplements/analysis ; Double-Blind Method ; Feces/microbiology ; Female ; Humans ; Keratin-18/genetics ; Keratin-18/metabolism ; Kidney Failure, Chronic/drug therapy ; Kidney Failure, Chronic/metabolism ; Kidney Failure, Chronic/microbiology ; Kidney Failure, Chronic/therapy ; Lactobacillus acidophilus/physiology ; Lactobacillus casei/physiology ; Male ; Middle Aged ; Probiotics/administration & dosage ; Renal Dialysis ; Synbiotics/administration & dosage
    Chemical Substances Cell Adhesion Molecules ; Keratin-18
    Language English
    Publishing date 2018-10-02
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2487792-X
    ISSN 1867-1314 ; 1867-1306
    ISSN (online) 1867-1314
    ISSN 1867-1306
    DOI 10.1007/s12602-018-9477-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Evaluation of administration of oral N-acetylcysteine to reduce oxidative stress in chronic hemodialysis patients: A double-blind, randomized, controlled clinical trial.

    Shahbazian, Heshmatollah / Shayanpour, Shokouh / Ghorbani, Ali

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

    2016  Volume 27, Issue 1, Page(s) 88–93

    Abstract: This study was designed to assess the efficacy of N-acetylcysteine (NAC) on the reduction of oxidative stress in chronic hemodialysis (HD) patients through measurement of total serum anti-oxidant capacity. In this randomized, double-blind, controlled ... ...

    Abstract This study was designed to assess the efficacy of N-acetylcysteine (NAC) on the reduction of oxidative stress in chronic hemodialysis (HD) patients through measurement of total serum anti-oxidant capacity. In this randomized, double-blind, controlled clinical trial, the efficacy and safety of NAC in reduction of oxidative stress was evaluated in 40 chronic HD patients. The study was conducted at the HD Department of the Golestan Hospital, Ahvaz, Iran. Data were analyzed using SPSS version 19. Paired samples test showed that the mean score of the serum level of total anti-oxidant capacity (TAC) increased from 26.39±17.03 to 33.26±18.8 (Pvalue=0.01) and from 24.02±16.47 to 25.38±17.04 (P=0.1) in the NAC and placebo groups, respectively. Difference in the mean TAC changes between groups was statistically significant (P=0.042). In our study, NAC administration could reduce oxidative stress in chronic HD patients. No major side-effects were observed.
    MeSH term(s) Acetylcysteine/administration & dosage ; Adult ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Free Radical Scavengers/administration & dosage ; Humans ; Kidney Failure, Chronic/metabolism ; Kidney Failure, Chronic/therapy ; Male ; Oxidative Stress/drug effects ; Prospective Studies ; Renal Dialysis ; Time Factors ; Treatment Outcome
    Chemical Substances Free Radical Scavengers ; Acetylcysteine (WYQ7N0BPYC)
    Language English
    Publishing date 2016-01
    Publishing country Saudi Arabia
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1379955-1
    ISSN 1319-2442
    ISSN 1319-2442
    DOI 10.4103/1319-2442.174084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Diabetes and end-stage renal disease; a review article on new concepts.

    Ghaderian, Seyed Bahman / Hayati, Fatemeh / Shayanpour, Shokouh / Beladi Mousavi, Seyed Seifollah

    Journal of renal injury prevention

    2015  Volume 4, Issue 2, Page(s) 28–33

    Abstract: It is well established that diabetic nephropathy is the most common cause or in combination with hypertensive nephropathy are the most common causes of end-stage renal disease (ESRD) in developed and developing countries. For this review, we used a ... ...

    Abstract It is well established that diabetic nephropathy is the most common cause or in combination with hypertensive nephropathy are the most common causes of end-stage renal disease (ESRD) in developed and developing countries. For this review, we used a variety of sources by searching through PubMed, Embase, Scopus, Current Content and Iran Medex from January 1990 up to December 2014. Manuscripts published in English and Persian languages, as full-text articles, and or as abstract were included in the study. Patient survival in diabetics on maintenance renal replacement therapy including hemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation is significantly lower than that seen in nondiabetics with ESRD. The poor prognosis of diabetic patients with ESRD is partly due to presence of significant cardiovascular disease, problems with vascular access, more susceptible to infections, foot ulcer, and hemodynamic instability during HD. Although, many complications related to kidney transplantation may occur in diabetic ESRD patients, multiple studies have found that the kidney transplantation is the preferred renal replacement therapy for diabetic patients with ESRD and it is associated with a much better survival and quality of life than dialysis among these patients.
    Language English
    Publishing date 2015-06-01
    Publishing country Iran
    Document type Journal Article ; Review
    ZDB-ID 2747305-3
    ISSN 2345-2781
    ISSN 2345-2781
    DOI 10.12861/jrip.2015.07
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top